Patel Kinnari 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Patel Kinnari
See Remarks
Transactions
- Award
Common Stock
2025-02-11+57,786→ 450,181 total - Award
Stock Option (Right to Buy)
2025-02-11+172,214→ 172,214 totalExercise: $9.88Exp: 2035-02-11→ Common Stock (172,214 underlying)
Holdings
- 5,675(indirect: By Spouse)
Common Stock
- 104,927(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.
- [F3]This option represents a right to purchase a total of 172,214 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.